HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Mulkerin Selected Research

1,24-dihydroxyvitamin D2

12/2015A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Mulkerin Research Topics

Disease

9Neoplasms (Cancer)
10/2017 - 11/2002
4Colorectal Neoplasms (Colorectal Cancer)
06/2012 - 01/2002
3Adenocarcinoma
06/2012 - 01/2005
2Breast Neoplasms (Breast Cancer)
10/2017 - 12/2010
2Fatigue
12/2015 - 01/2002
2Liver Diseases (Liver Disease)
05/2012 - 08/2003
2Carcinoma (Carcinomatosis)
09/2011 - 01/2005
1Disease Progression
10/2017
1Death (Near-Death Experience)
10/2017
1Colonic Neoplasms (Colon Cancer)
09/2016
1Urinary Tract Infections (Urinary Tract Infection)
12/2015
1Neuroendocrine Carcinoma
01/2011
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2008
1Hepatocellular Carcinoma (Hepatoma)
01/2008
1Dyspnea (Shortness of Breath)
01/2008
1Diarrhea
01/2008
1Esophageal Neoplasms (Esophageal Cancer)
01/2005
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2005
1Neoplasm Metastasis (Metastasis)
08/2003
1Lymphoma (Lymphomas)
11/2002
1Eructation (Eructations)
01/2002
1Vomiting
01/2002
1Nausea
01/2002
1Anorexia
01/2002

Drug/Important Bio-Agent (IBA)

4Oxaliplatin (Eloxatin)FDA LinkGeneric
06/2012 - 07/2003
3GemcitabineFDA Link
06/2008 - 11/2002
2Bortezomib (Velcade)FDA Link
05/2012 - 12/2011
2PlatinumIBA
09/2011 - 08/2003
2CreatinineIBA
01/2008 - 08/2003
1Biomarkers (Surrogate Marker)IBA
09/2016
1Vitamin DFDA LinkGeneric
12/2015
1Alkaline PhosphataseIBA
12/2015
11,24-dihydroxyvitamin D2IBA
12/2015
1Tyrosine Kinase InhibitorsIBA
06/2012
1Monoclonal AntibodiesIBA
06/2012
1Capecitabine (Xeloda)FDA Link
06/2012
1Irinotecan (Camptosar)FDA LinkGeneric
06/2012
1Lapatinib (GW572016)FDA Link
06/2012
1Cisplatin (Platino)FDA LinkGeneric
09/2011
1Carboplatin (JM8)FDA LinkGeneric
09/2011
1satraplatin (JM 216)IBA
09/2011
1Valproic Acid (Depakote)FDA LinkGeneric
01/2011
1Zoledronic Acid (Zometa)FDA Link
12/2010
1lestaurtinibIBA
06/2008
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2008
1Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2008
1Growth Hormone (Somatotropin)IBA
01/2008
1Octreotide (Sandostatin)FDA LinkGeneric
01/2008
1Biological ProductsIBA
01/2008
1Leucovorin (Folinic Acid)FDA Link
01/2005
1Fluorouracil (Carac)FDA LinkGeneric
01/2005
1Pharmaceutical PreparationsIBA
08/2003
1eniluracilIBA
11/2002
1perillyl alcoholIBA
01/2002

Therapy/Procedure

7Drug Therapy (Chemotherapy)
10/2017 - 08/2003
4Therapeutics
10/2017 - 01/2002
1Liver Transplantation
08/2003